2025 annual financial data
Neurocrine Biosciences 2025 Operating margin
Neurocrine Biosciences 2025 operating margin with verified reported values.
Direct answer
Operating margin was 21.64%.
Operating income was 619,100,000 USD and net income was 478,600,000 USD.
Operating cash flow was 782,700,000 USD.
Get free Neurocrine Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,860,500,000 USD
- Operating income
- 619,100,000 USD
- Net income
- 478,600,000 USD
- Operating cash flow
- 782,700,000 USD